SCHEMBL21934192

SCHEMBL21934192

c1ccc(-c2ccc(-c3nc(-c4ccccc4)cc(-c4cccc(-c5cccc(-c6cccc7c(-c8ccccc8)nc8ccccc8c67)c5)c4)n3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
HPGD P15428 4/20 0.44
LMNA P02545 4/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 3/20 0.44
ATM Q13315 1/20 0.44
GLA P06280 1/20 0.44
NTSR1 P30989 1/20 0.42
DHODH Q02127 2/20 0.40
ACACA Q13085 2/20 0.39
ACHE P22303 1/20 0.38
MAOB P27338 3/20 0.37
MAOA P21397 2/20 0.37
ADORA2A P29274 2/20 0.37
ADORA1 P30542 1/20 0.37
NUDT1 P36639 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PDE10A Q9Y233 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21934640 1.00 MEN1 (0.44) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21934122 0.99 MEN1 (0.45) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21934187 0.99 MEN1 (0.45) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21934150 0.99 MEN1 (0.45) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21934951 0.99 MEN1 (0.45) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21934900 0.99 MEN1 (0.45) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21934899 0.99 MEN1 (0.45) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21934067 0.97 MEN1 (0.44) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21933721 0.97 MEN1 (0.44) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL21934626 0.97 MEN1 (0.44) MEN1KMT2AHPGDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131133-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME HEESUNG MATERIAL LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131133-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MEN1 343/4885KMT2A 794/4885HPGD 1048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.